To the intranucleolar translocation of AgNORs in leukemic early granulocytic and plasmacytic precursors
Language English Country Germany Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Silver Staining MeSH
- Cell Nucleolus metabolism MeSH
- Cell Cycle physiology MeSH
- K562 Cells MeSH
- Bone Marrow Cells metabolism MeSH
- DNA, Neoplasm metabolism MeSH
- Granulocytes metabolism ultrastructure MeSH
- HL-60 Cells MeSH
- Leukemia metabolism MeSH
- Humans MeSH
- Nucleolus Organizer Region metabolism MeSH
- Plasma Cells metabolism ultrastructure MeSH
- RNA, Neoplasm metabolism MeSH
- Cellular Senescence physiology MeSH
- Protein Transport MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- DNA, Neoplasm MeSH
- RNA, Neoplasm MeSH
Early leukemic granulocytic and plasmacytic precursors were studied in vitro and in vivo to provide an information on the intranucleolar distribution of AgNORs (silver stained nucleolus organizer regions). In most of these cells AgNORs appeared as clusters of silver stained particles distributed in the whole nucleolar body. On the other hand, in some leukemic early granulocytic precursors, i.e., in myeloblasts and promyelocytes enlarged AgNORs were translocated in the nucleolar peripheral part. In addition, the number of translocated AgNORs at the nucleolar periphery was significantly smaller. Such translocation of a reduced number of AgNORs was easily produced by experimental aging, i.e., starving of cultured leukemic early granulocytic precursors (HL-60 and K562 cells) in vitro and seems to be reversible. Similar translocation of a reduced number of AgNORs was also produced by aging of leukemic plasmacytic precursors. Thus, the translocation of the reduced number of AgNORs to the nucleolar periphery in some blastic leukemic hematopoietic cells might be an useful marker of their aging at the single cell level. However, more studies in this direction are required in the future.
See more in PubMed
J Cell Sci. 1994 Feb;107 ( Pt 2):639-48 PubMed
Eur J Histochem. 2003;47(1):39-43 PubMed
Eur J Histochem. 2002;46(2):125-32 PubMed
Neoplasma. 1990;37(3):253-66 PubMed
Life Sci. 2004 Jul 2;75(7):791-6 PubMed
J Photochem Photobiol B. 2004 Jan 23;73(1-2):67-78 PubMed
J Photochem Photobiol B. 2000 Dec;59(1-3):80-6 PubMed
Braz J Med Biol Res. 1999 Dec;32(12 ):1473-8 PubMed
Histochemistry. 1981;72(2):301-13 PubMed
Folia Biol (Praha). 2004;50(1):15-20 PubMed
Nature. 1964 Jul 4;203:92-4 PubMed
Herz. 1999 May;24(3):189-95 PubMed
Acta Histochem. 1999 Apr;101(2):167-83 PubMed
Exp Gerontol. 2001 Apr;36(4-6):607-18 PubMed
Folia Haematol Int Mag Klin Morphol Blutforsch. 1969;91(4):381-94 PubMed
Int Rev Cytol. 1980;65:255-99 PubMed
Exp Gerontol. 1998 Aug;33(5):393-419 PubMed
Exp Cell Res. 1963;24:SUPPL9:3-14 PubMed
J Oral Pathol Med. 2001 Apr;30(4):193-9 PubMed
Micron. 2000 Apr;31(2):117-20 PubMed
Biochem Pharmacol. 1999 Jun 1;57(11):1265-73 PubMed
Proc Soc Exp Biol Med. 1981 Apr;166(4):546-50 PubMed
Biol Cell. 1987;59(2):113-20 PubMed
Methods Cell Biol. 1998;53:303-21 PubMed
Acta Histochem. 2001 Jul;103(3):325-33 PubMed
Virchows Arch A Pathol Anat Histopathol. 1993;423(6):409-16 PubMed
J Cell Sci. 2001 Sep;114(Pt 17):3199-205 PubMed
Acta Histochem. 1998 Jul;100(3):257-70 PubMed
